HMGB1 and cholesteatoma: Semi-quantitative analysis of these blots indicated significantly increased levels of HMGB1 in plasma-derived sEVs of cholesteatoma patients relative to the normal control sEVs (fold change: 3.95 ± 1.02 and 1.00 ± 0.58, respectively; p < 0.05; Figure 2C).